RBC Capital Markets Raises Price Target on Gilead Sciences
RBC Capital Markets increased its price target for Gilead Sciences to $131 from $126 while maintaining a 'Sector Perform' rating.
Stocks · News reference
Gilead CEO Takes Aim at Medicare Pricing: 'Pill Penalty' Threatens Drug Innovation
Gilead stock rose after Q3 earnings beat Wall Street estimates and strong HIV drug demand prompted an increased 2026 sales forecast.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Incyte To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Friday
Analysts raised targets for Cheniere and Incyte, while cutting Stryker, Roblox, Intel and Honeywell; Bright Horizons was downgraded.
Cantor Fitzgerald and Needham Update Gilead Sciences Ratings
Analysts at Cantor Fitzgerald and Needham maintained positive ratings on Gilead Sciences following the company's third-quarter earnings report.
Gilead Sciences and Assembly Biosciences Update Collaboration on ABI-6250
Gilead Sciences maintains an option to license Assembly Biosciences' ABI-6250 for chronic HDV infection following the completion of a Phase 2 clinical study.
Gilead Sciences Announces Third Quarter 2026 Financial Results
Gilead Sciences reported strong third-quarter 2026 financial results, exceeding analyst expectations for both revenue and earnings per share, and raised its full-year base business revenue guidance.
Breakfast News: Brace for an AI Optics Shake-up
Marvell is reportedly in advanced talks to acquire Lumentum to control AI optics supply, a critical bottleneck in AI infrastructure. Alphabet slumped 10% despite strong cloud growth due to massive capital expenditures and negative free cash flow. Several earnings reports showed mixed results: Fortinet fell 25% on weak guidance, ServiceNow dropped 19% due to AI deployment costs, while Microsoft, Sterling Infrastructure, and Chipotle posted gains. DoorDash may acquire Instacart to compete in grocery delivery dominated by Instacart's 68% market share.